Medlab Clinical Limited filed its F-1 on Oct 13, 2022 for the period ending Jun 30, 2022. In this report its auditor, Accell Audit & Compliance, P.A, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.6 AUD | -.--% | -5.04% | -.--% |
Apr. 24 | Medlab Clinical Limited Reports Earnings Results for the Full Year Ended June 30, 2023 | CI |
Feb. 29 | Medlab Clinical Limited Announces Change of Share Registry | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 9.83M | |
-2.44% | 103B | |
+1.74% | 95.28B | |
+1.46% | 22.15B | |
-15.77% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.04% | 16.05B | |
+5.34% | 13.68B | |
+34.35% | 12.17B |
- Stock Market
- Equities
- MDC Stock
- News Medlab Clinical Limited
- Medlab Clinical Limited Auditor Raises 'Going Concern' Doubt